BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31917237)

  • 1. Deguelin inhibits HCV replication through suppressing cellular autophagy via down regulation of Beclin1 expression in human hepatoma cells.
    Liao W; Liu X; Yang Q; Liu H; Liang B; Jiang J; Huang J; Ning C; Zang N; Zhou B; Liao Y; Chen J; Tian L; Ho W; Abdullah AS; Kong L; Liang H; Chen H; Ye L
    Antiviral Res; 2020 Feb; 174():104704. PubMed ID: 31917237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of autophagy-related gene ATG5 and GABARAP expression by IFN-λ1 contributes to its anti-HCV activity in human hepatoma cells.
    Li X; Li Y; Fang S; Su J; Jiang J; Liang B; Huang J; Zhou B; Zang N; Ho W; Li J; Li Y; Chen H; Ye L; Liang H
    Antiviral Res; 2017 Apr; 140():83-94. PubMed ID: 28131804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol-induced autophagy via upregulation of PIASy promotes HCV replication in human hepatoma cells.
    Ran M; Chen H; Liang B; Liao W; Jiang J; Huang J; Ning C; Zang N; Zhou B; Liao Y; Liu H; Qin F; Yang Q; Li J; Ho W; Liang H; Ye L
    Cell Death Dis; 2018 Sep; 9(9):898. PubMed ID: 30185779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of autophagy by mycophenolic acid contributes to inhibition of HCV replication in human hepatoma cells.
    Fang S; Su J; Liang B; Li X; Li Y; Jiang J; Huang J; Zhou B; Ning C; Li J; Ho W; Li Y; Chen H; Liang H; Ye L
    Sci Rep; 2017 Mar; 7():44039. PubMed ID: 28276509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.
    Laidlaw SM; Marukian S; Gilmore RH; Cashman SB; Nechyporuk-Zloy V; Rice CM; Dustin LB
    Gastroenterology; 2017 Aug; 153(2):566-578.e5. PubMed ID: 28456632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoid derivative Tp80 exhibits anti-hepatitis C virus activity through restoration of GI-GPx expression.
    Nguyen BN; Okuno Y; Ajiro M; Iida K; Denawa M; Yamamoto M; Sakamoto N; Kagechika H; Hagiwara M
    J Med Virol; 2017 Jul; 89(7):1224-1234. PubMed ID: 27922182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
    Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
    World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil inhibits hepatitis C virus replication in human hepatic cells.
    Ye L; Li J; Zhang T; Wang X; Wang Y; Zhou Y; Liu J; Parekh HK; Ho W
    Virus Res; 2012 Sep; 168(1-2):33-40. PubMed ID: 22728816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
    Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy induction plays time-dependent role in viral load of HCV infected Huh7.5 cell line.
    Abdoli M; Abdoli A; Aryan E; Meshkat Z
    IUBMB Life; 2019 Jan; 71(1):41-44. PubMed ID: 30290082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypericin inhibits hepatitis C virus replication via deacetylation and down-regulation of heme oxygenase-1.
    Shih CM; Wu CH; Wu WJ; Hsiao YM; Ko JL
    Phytomedicine; 2018 Jul; 46():193-198. PubMed ID: 30097118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Small Molecule Inhibits Hepatitis C Virus Propagation in Cell Culture.
    Oraby AK; Gardner CL; Needle RF; Kofahi HM; Everard KR; Taylor NGA; Rutihinda SG; Barry JP; Hirasawa K; Georghiou PE; Russell RS
    Microbiol Spectr; 2021 Sep; 9(1):e0043921. PubMed ID: 34319169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-infectivity of camel polyclonal antibodies against hepatitis C virus in Huh7.5 hepatoma.
    El-Fakharany EM; Abedelbaky N; Haroun BM; Sánchez L; Redwan NA; Redwan EM
    Virol J; 2012 Sep; 9():201. PubMed ID: 22978304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C.
    Ikeda M; Kawai Y; Mori K; Yano M; Abe K; Nishimura G; Dansako H; Ariumi Y; Wakita T; Yamamoto K; Kato N
    Liver Int; 2011 Jul; 31(6):871-80. PubMed ID: 21645219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.
    Kasai D; Adachi T; Deng L; Nagano-Fujii M; Sada K; Ikeda M; Kato N; Ide YH; Shoji I; Hotta H
    J Hepatol; 2009 May; 50(5):883-94. PubMed ID: 19303158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeic acid inhibits HCV replication via induction of IFNα antiviral response through p62-mediated Keap1/Nrf2 signaling pathway.
    Shen J; Wang G; Zuo J
    Antiviral Res; 2018 Jun; 154():166-173. PubMed ID: 29656059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deguelin inhibits human hepatocellular carcinoma by antiangiogenesis and apoptosis.
    Lee JH; Lee DH; Lee HS; Choi JS; Kim KW; Hong SS
    Oncol Rep; 2008 Jul; 20(1):129-34. PubMed ID: 18575727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response.
    Bauhofer O; Ruggieri A; Schmid B; Schirmacher P; Bartenschlager R
    Gastroenterology; 2012 Aug; 143(2):429-38.e8. PubMed ID: 22522091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aqueous extract of the edible Gracilaria tenuistipitata inhibits hepatitis C viral replication via cyclooxygenase-2 suppression and reduces virus-induced inflammation.
    Chen KJ; Tseng CK; Chang FR; Yang JI; Yeh CC; Chen WC; Wu SF; Chang HW; Lee JC
    PLoS One; 2013; 8(2):e57704. PubMed ID: 23469054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.